Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 41Carcinoma, Renal Cell 31Neoplasms 18Kidney Neoplasms 17Neuroendocrine Tumors 16Neoplasm Metastasis 13Tuberous Sclerosis 10Prostatic Neoplasms 8Carcinoma 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Glioma 7Glioblastoma 7Astrocytoma 7Waldenstrom Macroglobulinemia 6Triple Negative Breast Neoplasms 6Recurrence 6Lymphoma 6Head and Neck Neoplasms 6Stomach Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Carcinoma, Neuroendocrine 5Brain Neoplasms 5Sezary Syndrome 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Mycosis Fungoides 4

Interventions

Cetuximab 6Cisplatin 4zalutumumab 3Radiotherapy 3Docetaxel 3Fluorouracil 2Carboplatin 2temsirolimus 1pembrolizumab 1osimertinib 1enzalutamide 1cobimetinib 1abemaciclib 1Taxes 1Sorafenib 1Risk Factors 1Radiation 1Papanicolaou Test 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Imatinib Mesylate 1Human Papillomavirus DNA Tests 1Gefitinib 1Everolimus 1Erlotinib Hydrochloride 1Cyclophosphamide 1Colposcopy 1Cilengitide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms, Squamous Cell × Everolimus × Clear all
NCT01111058 2020-04-07

Everolimus Versus Placebo in Head and Neck Cancer

University of Chicago

Phase 2 Terminated
52 enrolled 13 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡